VTRSViatris

Median target
$20
calls from the last 12 months
Implied return
+16.8%
median target vs. price
Coverage
9 analysts · 9 calls
updated in the last 12 months
Consensus
4/4/1+3 net
Buy / Hold / Sell

Which analysts are behind VTRS's consensus?

See every current rating, price target and the analysts' track records for Viatris — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 9 analysts with calls on VTRS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

VTRS elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2025-12-17ExecutiveTrump, Donald JPresidentPurchaseVIATRIS INC$1,001 - $15,000
2025-11-18CongressGilbert CisnerosCA-CA39Purchasesince trade +63.9%, vs market +47.8%$1K–$15K
2025-08-04ExecutiveTrump, Donald JPresidentPurchaseVIATRIS INC$1,001 - $150,008
2025-04-08CongressRob BresnahanPA-PA08Salesince trade +144.6%, vs market -89.4%$1K–$15K
2025-04-04ExecutiveTrump, Donald JPresidentPurchaseVIATRIS INC$15,001 - $500,004
2025-03-31CongressGilbert CisnerosCA-CA39Salesince trade +106.7%, vs market -69.0%$1K–$15K
2025-03-10ExecutiveTrump, Donald JPresidentSaleVIATRIS INC$1,001 - $150,003
2025-02-25CongressRob BresnahanPA-PA08Purchasesince trade +58.8%, vs market +28.8%$1K–$15K
2023-04-10CongressDaniel GoldmanNY-NY10Salesince trade +99.8%, vs market -6.6%$1K–$15K
2023-03-06CongressDaniel GoldmanNY-NY10Salesince trade +83.3%, vs market +13.1%$1K–$15K

More: congressional trades on VTRS · insider activity · executive branch · trending